መነሻ › የጡንቻ ካንሰር › Virginia › Arlington
በArlington፣ VA ለየጡንቻ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለየጡንቻ ካንሰር የሚደረጉ 46 ጥናቶች በArlington እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Virginia Cancer Specialists, Fairfax · 11 ማይል ርቀት
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Virginia Cancer Specialists, Fairfax · 11 ማይል ርቀት
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Inova Schar Cancer Institute, Fairfax · 11 ማይል ርቀት
- Virginia Cancer Specialists, PC, Fairfax · 11 ማይል ርቀት
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Inova Schar Cancer Institute, Fairfax · 11 ማይል ርቀት
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Inova Schar Cancer Institute, Fairfax · 11 ማይል ርቀት
Study of AVZO-021 in Patients With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 ማይል ርቀት
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Inova Schar Cancer Institute ( Site 0025), Fairfax · 11 ማይል ርቀት
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Fairfax · 11 ማይል ርቀት
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Virginia Cancer Specialists, Fairfax · 11 ማይል ርቀት
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
ተሳታዮችን በመፈለግ ላይ
- Inova, Fairfax · 11 ማይል ርቀት
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Virginia Cancer Specialists, Fairfax · 11 ማይል ርቀት
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Inova Schar Cancer Institute, Fairfax · 11 ማይል ርቀት
A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Next Virginia, Fairfax · 11 ማይል ርቀት
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- NEXT Oncology, Fairfax · 11 ማይል ርቀት
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Inova Schar Cancer Institute, Fairfax · 11 ማይል ርቀት
- Virginia Cancer Specialists, Fairfax · 11 ማይል ርቀት
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Virginia Cancer Specialists, Fairfax · 11 ማይል ርቀት
A Phase 1/1b Study of IAM1363 in HER2 Cancers
ተሳታዮችን በመፈለግ ላይደረጃ 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 ማይል ርቀት
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- NEXT Oncology, Fairfax · 11 ማይል ርቀት
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Virginia Cancer Specialists-Fairfax, Fairfax · 11 ማይል ርቀት
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Next Oncology, Fairfax · 11 ማይል ርቀት
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Virginia Cancer Specialists, PC, Fairfax · 11 ማይል ርቀት
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- NEXT Virginia, Fairfax · 11 ማይል ርቀት
The Vanguard Study: Testing a New Way to Screen for Cancer
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
- Inova Schar Cancer Institute, Fairfax · 11 ማይል ርቀት
- Inova Fair Oaks Hospital, Fairfax · 11 ማይል ርቀት
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 ማይል ርቀት
- Kaiser Permanente-Burke Medical Center, Burke · 11 ማይል ርቀት
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- NEXT Virginia, Fairfax · 11 ማይል ርቀት
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- NEXT Virginia, Fairfax · 11 ማይል ርቀት
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Inova Schar Cancer Institute, Falls Church · 4 ማይል ርቀት
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Inova Schar Cancer Institute, Fairfax · 11 ማይል ርቀት
- Inova Fair Oaks Hospital, Fairfax · 11 ማይል ርቀት
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Virginia Cancer Specialists, Fairfax · 11 ማይል ርቀት
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- USOR Virginia Cancer Specialists, Fairfax · 11 ማይል ርቀት
E-Mindfulness Approaches for Living After Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Inova Fairfax Hospital, Falls Church · 4 ማይል ርቀት
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 ማይል ርቀት
- Inova Schar Cancer Institute, Fairfax · 11 ማይል ርቀት
- እና 1 ተጨማሪ
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- NEXT Virginia, Fairfax · 11 ማይል ርቀት
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 ማይል ርቀት
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- INOVA Schar Cancer, Fairfax · 11 ማይል ርቀት
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- NEXT Oncology Virginia, Fairfax · 11 ማይል ርቀት
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- NEXT, Fairfax · 11 ማይል ርቀት
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Virginia Cancer Specialists, Fairfax · 11 ማይል ርቀት
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Inova Schar Cancer Institute ( Site 0051), Fairfax · 11 ማይል ርቀት
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Virginia Cancer Specialists, PC, Reston · 14 ማይል ርቀት
- Virginia Cancer Specialists, Manassas · 22 ማይል ርቀት
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Virginia Cancer Specialists, Fairfax · 11 ማይል ርቀት
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- NEXT Oncology Virginia, Fairfax · 11 ማይል ርቀት
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- NEXT Virginia, Fairfax · 11 ማይል ርቀት
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Virginia Cancer Specialists, Fairfax · 11 ማይል ርቀት
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- NEXT, Virginia, Fairfax · 11 ማይል ርቀት
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Inova Schar Cancer Center, Fairfax · 11 ማይል ርቀት
- NEXT Virginia, Fairfax · 11 ማይል ርቀት
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Biotheryx Investigative Site, Fairfax · 11 ማይል ርቀት
በሌሎች ከተሞች ለየጡንቻ ካንሰር የሚደረጉ ጥናቶች
- New York City, NY134 ጥናቶች
- Houston, TX126 ጥናቶች
- Boston, MA111 ጥናቶች
- Nashville, TN80 ጥናቶች
- Los Angeles, CA72 ጥናቶች
- Edison, NJ68 ጥናቶች
- St. Louis, MO64 ጥናቶች
- Durham, NC63 ጥናቶች
- Queens, NY63 ጥናቶች
- Chicago, IL58 ጥናቶች
- Philadelphia, PA56 ጥናቶች
- Dallas, TX55 ጥናቶች
በArlington ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር104 ጥናቶች
- Metastatic Cancer53 ጥናቶች
- የኮሎሬክታል ካንሰር52 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)48 ጥናቶች
- የእንቁላል ካንሰር46 ጥናቶች
- የሳንባ ካንሰር41 ጥናቶች
- የኤንዶሜትሪየም ካንሰር39 ጥናቶች
- የፓንክሪያስ ካንሰር33 ጥናቶች
- የራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ26 ጥናቶች
- Small Cell የሳንባ ካንሰር23 ጥናቶች
- ትሪፕል-ኔጌቲቭ የደረት ካንሰር20 ጥናቶች
- የሆድ ካንሰር20 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።